REG - Obrascon Huarte Lain - Notice of Convening Hearing

Obrascon Huarte Lain SAAnnouncement

16/03/2021 15:45

RNS Number : 4603S
  
Obrascon Huarte Lain, S.A.
  
16 March 2021
  
 

OBRASCÓN HUARTE LAIN, S.A. ("OHL" or the "Company"), pursuant to article 227 of the consolidated text of the Securities Market Act approved by Royal Legislative Decree 4/2015, of 23 October, hereby notifies the Spanish National Securities Market Commission (Comisión Nacional del Mercado de Valores) ("CNMV") the following
OTHER RELEVANT INFORMATION NOTICE
In connection with the communication of inside information dated 25 February 2021 (with number 768) by virtue of which the Company informed, among others, of the launch of the practice statement letter in connection with the Scheme (the "Practice Statement Letter"), the Company informs that it has been confirmed that the convening hearing in relation to the Scheme has now been fixed to take place on Thursday 18 March 2021 at 10:30 a.m. (London time) before Mr Justice Adam Johnson in the Rolls Building, Fetter Lane, London, EC4A 1NL. Attendance will be available via video conference in light of the COVID-19 pandemic.
The Convening Hearing is for an order granting the Company certain directions in relation to the Scheme including permission to convene a meeting of the Scheme Creditors for the purpose of considering and, if thought fit, approving to the Scheme.
Any interested party has the right to attend via Skype either themselves or through counsel and make representations at the Convening Hearing. In order to access the Convening Hearing, any interested party should provide their details via email to ohl@lucid-is.com for the attention of Paul Kamminga and Victor Parzyjagla by 9:00 a.m. (London time) on 17 March 2021, following which they will be provided a Skype link directly by the Court.
Capitalised terms used but not defined in this notice shall have the meaning given to them in the Practice Statement Letter.
Madrid 16 March 2021
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCDZGMFKVMGMZM